- Home
- OZK vs MRUS Comparison
OZK vs MRUS Comparison
Compare OZK & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OZK | MRUS |
|---|---|---|
| Founded | 1903 | 2003 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.1B |
| IPO Year | 1997 | 2016 |
Fundamental Metrics
Financial Performance| Metric | OZK | MRUS |
|---|---|---|
| Price | $48.29 | $96.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 17 |
| Target Price | $55.38 | ★ $94.94 |
| AVG Volume (30 Days) | 1.0M | ★ 1.4M |
| Earning Date | 01-15-2026 | 10-31-2025 |
| Dividend Yield | ★ 3.61% | N/A |
| EPS Growth | ★ 1.97 | N/A |
| EPS | ★ 6.20 | N/A |
| Revenue | ★ $1,539,084,000.00 | $56,606,000.00 |
| Revenue This Year | $17.94 | $56.08 |
| Revenue Next Year | $0.86 | N/A |
| P/E Ratio | $7.85 | ★ N/A |
| Revenue Growth | 5.38 | ★ 57.54 |
| 52 Week Low | $35.71 | $33.19 |
| 52 Week High | $53.66 | $96.94 |
Technical Indicators
Market Signals| Indicator | OZK | MRUS |
|---|---|---|
| Relative Strength Index (RSI) | 61.92 | 70.73 |
| Support Level | $46.47 | $96.60 |
| Resistance Level | $49.28 | $96.94 |
| Average True Range (ATR) | 0.99 | 0.22 |
| MACD | 0.39 | -0.14 |
| Stochastic Oscillator | 74.82 | 85.00 |
Price Performance
Historical ComparisonAbout OZK Bank OZK
Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit, and individual retirement accounts to loan services like real estate, consumer, commercial, and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking, and other related services.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.